Cost-effectiveness of postmastectomy hypofractionated radiation therapy vs conventional fractionated radiation therapy for high-risk breast cancer

BACKGROUND: The phase 3 NCT00793962 trial demonstrated that postmastectomy hypofractionated radiation therapy (HFRT) was noninferior to conventional fractionated radiation therapy (CFRT) in patients with high-risk breast cancer. This study assessed the cost-effectiveness of postmastectomy HFRT vs CF...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jing, Qi, Shu-Nan, Fang, Hui, Song, Yong-Wen, Jin, Jing, Liu, Yue-Ping, Wang, Wei-Hu, Yang, Yong, Tang, Yu, Ren, Hua, Chen, Bo, Lu, Ning-Ning, Tang, Yuan, Li, Ning, Jing, Hao, Wang, Shu-Lian, Li, Ye-Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105681/
https://www.ncbi.nlm.nih.gov/pubmed/33933925
http://dx.doi.org/10.1016/j.breast.2021.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105681/
https://www.ncbi.nlm.nih.gov/pubmed/33933925
http://dx.doi.org/10.1016/j.breast.2021.04.002

Ejemplares similares